Guardian Pharmacy Services, Inc. Total Liabilities

Latest as of March 2026: $194.52 Million USD

Guardian Pharmacy Services, Inc. total liabilities. Based on the latest financial reports, Guardian Pharmacy Services, Inc. (GRDN) has total liabilities worth $194.52 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See GRDN days of operational coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Guardian Pharmacy Services, Inc. (2018–2025)

Total liabilities of Guardian Pharmacy Services, Inc. from 2018 to 2025. This chart illustrates how Guardian Pharmacy Services, Inc.'s total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Guardian Pharmacy Services, Inc. generate to measure how efficiently the company converts operating cash flow to free cash.

Guardian Pharmacy Services, Inc. Competitors by Total Liabilities

The table below lists competitors of Guardian Pharmacy Services, Inc. ranked by their total liabilities.

Company Country Total Liabilities
Isrotel -L
TA:ISRO
Israel ILA2.62 Billion
Chemours Co
NYSE:CC
USA $7.27 Billion
China Merchants Securities Co. Ltd
F:195H
Germany €646.99 Billion
PSG Konsult Ltd
JSE:KST
South Africa ZAC151.99 Billion
AMP Limited
F:AMP
Germany €30.47 Billion
Sinocelltech Group Ltd
SHG:688520
China CN¥4.49 Billion
U-Ming Marine Transport Corp
TW:2606
Taiwan NT$51.03 Billion
Triumph Group Inc
NYSE:TGI
USA $1.70 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Guardian Pharmacy Services, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Guardian Pharmacy Services, Inc. asset portfolio.

Liquidity & Leverage Metrics

Guardian Pharmacy Services, Inc. Total Liabilities Ratios Explained

Guardian Pharmacy Services, Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.46 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.88 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.46 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guardian Pharmacy Services, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guardian Pharmacy Services, Inc. (2018–2025)

The table below shows the annual total liabilities of Guardian Pharmacy Services, Inc. from 2018 to 2025.

Year Total Liabilities Change
2025-12-31 $194.73 Million +13.99%
2024-12-31 $170.83 Million -19.15%
2023-12-31 $211.31 Million +17.27%
2022-12-31 $180.18 Million -1.29%
2021-12-31 $182.53 Million +21.04%
2020-12-31 $150.80 Million +8.12%
2019-12-31 $139.47 Million +22.56%
2018-12-31 $113.80 Million --

About Guardian Pharmacy Services, Inc.

NYSE:GRDN USA Medical Care Facilities
Market Cap
$2.03 Billion
Market Cap Rank
#5891 Global
#1930 in USA
Share Price
$40.69
Change (1 day)
+0.59%
52-Week Range
$27.03 - $48.00
All Time High
$48.00
About

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health… Read more